Future Directions in Intelligence Enhancement
Linas JuozenasShare
Tomorrow’s brain, built wisely
Gene editing, neural interfaces, medicines and artificial intelligence may protect or extend human cognition—but they do not all exist at the same level of evidence. This guide separates present reality from promising experiments and distant speculation, then asks the question that matters most: how can progress strengthen human intelligence without surrendering autonomy, originality or fair access?
Education, health, demanding practice and lifelong learning can strengthen measured ability without waiting for futuristic technology.
The clearest gains come from helping people communicate, move, see or manage disease—not elective super-intelligence.
Cognitive traits are highly polygenic and shaped across development by biology, education and environment.
A drug may change wakefulness or a narrow task without safely raising general intelligence or wisdom.
Design determines whether AI strengthens independent ability or merely produces an answer on demand.
A future map needs a scale
The phrase cognitive enhancement can hide four very different ambitions: preventing injury, treating illness, restoring a lost function and extending an already healthy ability. The farther we move from treatment toward elective augmentation, the thinner the human evidence usually becomes.
A mechanism is not a medicine. A successful animal experiment is not a safe human therapy. A regulatory authorization for one disease is not proof of benefit for healthy people. And a faster answer is not necessarily a stronger mind.
| Purpose | Example | Evidence question | Ethical pressure point |
|---|---|---|---|
| Prevent | Reduce a known cause of neurological disease before damage occurs. | Is the cause sufficiently certain, and is intervention safer than surveillance or conventional care? | Testing, consent, reproductive choice and unequal access. |
| Treat | Reduce symptoms of epilepsy, depression, ADHD or another diagnosed condition. | Does benefit exceed risk for this condition, person and endpoint? | Clinical need, side effects, monitoring and freedom from stigma. |
| Restore | Return speech, movement, vision or memory after injury or disease. | Is the function meaningfully usable outside a laboratory, and for how long? | Device maintenance, cybersecurity, abandonment and control of data. |
| Augment | Push a healthy ability beyond its present range. | Is there replicated improvement in real life—not merely on a narrow test? | Coercion, competition, identity, fairness and who can afford it. |
Claims that survive hard questions
- A clearly defined population, comparator and outcome.
- Independent replication, not only a company announcement.
- Absolute effects and adverse events, not just relative percentages.
- Follow-up long enough to reveal durability and delayed harm.
- A transparent regulatory status and registered study protocol.
Signals of enhancement theatre
- “Clinically proven” without a named trial or approved indication.
- A mouse, cell or brain-scan finding translated directly into a human promise.
- One improved subtest presented as an increase in intelligence.
- Testimonials standing in for blinded comparison.
- Urgency, secrecy or a requirement to buy before reviewing evidence.
Editing disease is not editing destiny
Genome editing has crossed an historic threshold: CRISPR-based treatments now exist for particular blood disorders. That achievement is real. It does not mean that clinicians can safely rewrite a healthy person’s intelligence, personality or future.
A genuine milestone
In 2023, the FDA authorized a CRISPR/Cas9-edited therapy for sickle cell disease. Cells are removed, edited outside the body and returned after intensive conditioning. This demonstrates therapeutic genome editing under tightly defined conditions—not effortless, whole-body enhancement.1
Neurological targets
Researchers are exploring direct genome editing and epigenetic control for inherited neurological disorders. The brain creates additional barriers: delivery, cell-type precision, immune response, unintended changes and the practical irreversibility of edits already delivered across millions of cells.
General intelligence
There is no validated gene edit that safely raises general intelligence. Cognitive performance is influenced by very many genetic variants of tiny effect, development, health, education and experience. Changing one variant cannot be assumed to produce a predictable mind.
Single-gene disorders and complex traits are different problems
A pathogenic variant can sometimes be a major cause of a rare disorder. That gives researchers a comparatively clear target: correct, replace, silence or compensate for a defined molecular error. Even then, timing and delivery matter; preventing damage may be easier than reversing a brain that has already developed under the condition.
Intelligence is different. Genome-wide studies indicate that cognitive ability is highly polygenic: many variants contribute, each with a small statistical association, and their effects unfold within environments.2 A polygenic score summarizes weighted genetic associations and may estimate relative propensity within a studied population; it is not a molecular blueprint, a diagnosis or a forecast of one individual’s ceiling.
This complexity does not make genes unimportant. It makes simplistic promises irresponsible. Biological inheritance helps shape cognitive differences, while development and sustained learning build the functioning person. Respect for intelligence therefore includes respect for both inherited variation and the years of effort through which knowledge, judgment and expertise are formed.
| Approach | Who is changed? | Present direction | Central limits |
|---|---|---|---|
| Somatic editing | Cells in the treated person; changes are not intended to be inherited. | Authorized for a few diseases and studied for others. | Delivery, off-target and unintended on-target changes, immune effects, durability and cost. |
| Heritable editing | Eggs, sperm or embryos; changes may pass to future generations. | Basic research and governance debate; not accepted for initiating pregnancy in responsible clinical practice. | Future people cannot consent; mosaicism and unintended effects may be inherited; alternatives often exist; social consequences are profound. |
A change can be technically possible and still not be ready—or right
The World Health Organization’s governance recommendations call for robust oversight, registries, international cooperation, public engagement and action against unsafe or unethical genome-editing activity.3 An international commission convened by the U.S. National Academies and the U.K. Royal Society concluded that heritable editing should not proceed unless stringent scientific and governance criteria can be met; at publication, they could not.4
For cognitive traits, those barriers are higher still. We do not know how to specify a safe edit, forecast its lifelong effects or separate a desired change from trade-offs in other traits. Claims that embryo selection or editing can reliably design exceptional intelligence run far ahead of evidence.
Promising research directions
- Safer delivery to specific cells and tissues.
- More accurate measurement of intended and unintended edits.
- Reversible control of gene expression where possible.
- Treatments for severe, well-understood neurological disease.
- Long-term registries that follow benefits and harms.
Questions no headline can skip
- Is the intervention treating suffering or imposing a preferred norm?
- Are disability communities included in defining benefit?
- Could surveillance, insurance or reproductive pressure follow testing?
- Who owns the samples, sequence and resulting discoveries?
- Who receives the benefit if public research carries the risk?
The strongest neurotechnology reconnects a person to life
Neural devices are already valuable in medicine, and research systems can translate intended movement or speech into action. Their most credible trajectory is restoration: routing information around damaged pathways, modulating a disease circuit or supplying a missing sensory channel.
Neuromodulation
Deep-brain stimulation and non-invasive stimulation have device- and condition-specific uses. Authorization never generalizes automatically to healthy enhancement.
Speech and movement
Implants can decode intended speech or movement for individual people with paralysis. Reliability, setup, longevity and access remain active research problems.
Memory support
Closed-loop stimulation has improved performance on specific laboratory memory tasks in small studies. It is not an approved “memory pacemaker.”
Cognitive co-processors
No implanted device has been clinically shown to offload working memory, upload knowledge or increase general intelligence. Hardware metaphors are not clinical evidence.
Communication without repaired neurons
A brain–computer interface can record patterns associated with intended speech or movement, decode them with software and control an external device. This may restore a route for action even when it does not heal the injured pathway. That is not a lesser accomplishment: communication, mobility and self-direction can transform a life.
China’s regulator authorized a minimally invasive extradural BCI in 2026 for a narrow group of adults with stable cervical spinal-cord injury to control an assistive glove.5 That authorization is significant because it moves a restorative interface into defined clinical use. It should not be reported as approval of a general brain implant, communication device or intelligence enhancer.
In a 2026 home study, one participant with amyotrophic lateral sclerosis used an implanted speech BCI for 19 months, with average decoding around 56 words per minute and caregiver-supported setup.6 It was a remarkable single-participant demonstration, not a consumer product and not evidence that thoughts can be read freely. These systems infer trained intentions from particular signals under particular conditions.
| Technology | Signal direction | Best-supported purpose | What it does not establish |
|---|---|---|---|
| Recording BCI | Brain → device | Decode trained movement or speech intentions for assistive control. | Unrestricted mind reading, repaired disease or general enhancement. |
| Stimulation | Device → nervous system | Modulate defined circuits or supply patterned sensory information. | Precise control of a complex trait such as wisdom, personality or intelligence. |
| Closed loop | Record → infer → stimulate | Respond to a detected state, such as a disease-related signal. | That the inferred state is perfect or that autonomous control is always appropriate. |
| Consumer sensing | Scalp/body → app | Estimate limited physiological or electrical features under noisy conditions. | Clinical diagnosis, exact emotion, private thought or validated cognitive improvement. |
Memory prosthesis: a careful name
Researchers have used recordings from people with epilepsy who already had temporary electrodes for clinical monitoring to model hippocampal activity and deliver patterned stimulation. One study reported improved performance on particular short-term and long-term memory tasks.7
This did not install memories, restore autobiographical identity or produce an approved dementia device. A task-level signal in a small, selected group must survive larger trials, everyday use, long follow-up and meaningful functional endpoints.
Electronic vision is not optogenetics
The PRIMA photovoltaic retinal prosthesis received a European CE mark in 2026 after a pivotal study in people with geographic atrophy. It supplies a form of central visual information through a subretinal electronic implant and external glasses.8
Optogenetic vision restoration is different and remains investigational. A 2021 report described partial object perception in one participant using a treated eye together with specialized goggles.9 Neither approach should be called normal sight or cognitive enhancement.
Brain access creates duties that ordinary gadgets do not
Continuity
Implanted users need maintenance, software support, component replacement and a plan if a company or trial ends.
Control
The person needs a clear way to pause, disconnect, understand updates and refuse secondary uses of neural data.
Security
Threat models must include unauthorized access, manipulation, inference and the consequences of device failure.
Non-invasive does not mean trivial
Transcranial magnetic stimulation (TMS) and transcranial direct-current stimulation (tDCS) affect the brain without surgery. Some devices are authorized for specific disorders. For example, in late 2025 the FDA approved a prescription tDCS system for a defined subset of adults with moderate-to-severe major depressive disorder.10 This says nothing by itself about use in healthy people, learning, creativity or general intelligence.
Stimulation studies are sensitive to electrode or coil placement, intensity, timing, individual anatomy, task and blinding. Small changes in experimental design can change the result. Consumer devices therefore deserve the same basic questions as medicines: what exact endpoint, compared with what, in whom, for how long, with what adverse-event monitoring?
The next engineering victories
- Longer-lasting, biocompatible interfaces with stable signals.
- Useful home performance rather than laboratory-only demonstrations.
- Faster calibration and less demanding caregiver setup.
- Accessible repair, replacement and long-term clinical support.
- Privacy-preserving computation and auditable update pathways.
The claims still outside evidence
- Uploading knowledge or downloading a memory.
- A chip that adds general intelligence across life.
- Reliable decoding of unconstrained private thought.
- Graphene or neuromorphic hardware functioning as a working-memory co-processor.
- Consumer EEG that accurately reads emotion or diagnoses a disorder.
A sharper hour is not a smarter life
Medicines can restore attention or wakefulness when a disorder impairs it. That therapeutic success does not establish that the same medicine will make a healthy, rested brain broadly more intelligent—and no medicine is approved to raise IQ in healthy people.
A statistically significant change on one computerized task after one dose is not the same as a meaningful improvement in learning, grades, work, judgment, creativity or long-term brain health.
Stimulants
Methylphenidate and amphetamine medicines are established treatments for ADHD and have other defined indications. In healthy, non-sleep-deprived adults, pooled acute effects are small and selective—not evidence of a durable rise in general intelligence.11
Wake-promoting medicines
Modafinil can improve wakefulness in particular diagnosed conditions. It does not provide biological recovery from missed sleep, and its approved labeling includes important dermatological, hypersensitivity, psychiatric, interaction and sleep-related cautions.12
Receptor-selective agents
One orexin-targeting medicine now has a defined disease approval, while dopamine- and neuroplasticity-related agents remain active research areas. Condition-specific treatment never establishes safe enhancement in healthy people.
Orexin shows why context matters
Narcolepsy type 1 involves loss of orexin-producing neurons. In August 2026, the U.S. FDA approved oveporexton, the first orexin-2 receptor agonist for adults with this condition, following two 12-week randomized trials.14 That is an important form of biological restoration: supplying a signal a disease has taken away. It is not evidence that a healthy person can safely eliminate sleep or gain supernormal cognition. Insomnia was among the common adverse reactions.
This distinction protects scientific progress from hype. A treatment can be revolutionary for the people who need it without becoming a universal “smart drug.”
Dopamine precision is not yet cognitive precision
Receptor selectivity is attractive because broad dopamine activation can produce unwanted effects. But a more selective mechanism still has to demonstrate meaningful outcomes. Mevidalen, a dopamine D1 positive allosteric modulator, reached phase II testing in dementia with Lewy bodies and did not meet its cognition endpoints; higher doses also raised safety concerns.15 Negative and neutral trials distinguish plausible mechanisms from treatments that meaningfully help people.
Plasticity is an opportunity, not intelligence in a bottle
So-called psychoplastogens are studied for their ability to promote structural or functional plasticity. Some non-hallucinogenic analogues have produced cellular and animal findings. Tabernanthalog, for example, has preclinical evidence—not established human cognitive benefit.16
A rise in BDNF, a dendritic-spine change or a “plasticity” label is a mechanism or biomarker. It does not prove better memory, reasoning or wisdom. Plasticity can enable learning and recovery, but experience determines what is learned; change can be adaptive, neutral or harmful.
Similarly, microdosing should not be marketed as settled cognitive enhancement. A preregistered 2026 meta-analysis of 14 studies found no overall cognitive benefit and a small reduction in cognitive control, with substantial limitations in the underlying literature.17
| Pathway | Defensible statement | Claim that goes too far |
|---|---|---|
| ADHD medicines | Can reduce symptoms and improve functioning for many appropriately diagnosed patients under clinical care. | They reliably make every healthy person more intelligent or improve long-term achievement. |
| Wake promotion | Can improve wakefulness for particular sleep disorders. | Wakefulness replaces sleep’s biological functions or removes accumulated sleep debt. |
| Psychoplastogens | Some compounds show promising plasticity-related mechanisms and are being studied as treatments. | More plasticity automatically means higher IQ, creativity or judgment. |
| Microdosing | Research can test subjective and cognitive effects under controlled conditions. | Current evidence proves a general cognitive upgrade. |
| Supplements | Correcting a genuine deficiency can protect cognition and health. | More of a nutrient must enhance a replete brain, or “natural” guarantees safe and accurately labeled. |
Personalized prescribing: real, but narrower
Pharmacogenomics can sometimes help explain drug exposure, dosing or adverse-reaction risk. It cannot yet look at a person’s DNA and reliably select the best “cognitive enhancer.” The FDA’s pharmacogenetic table lists specific gene–drug associations and repeatedly distinguishes pharmacokinetic knowledge from demonstrated improvement in clinical outcomes; it contains no validated panel that reliably predicts methylphenidate response.18
Genes are one input among age, organ function, other medicines, sleep, diagnosis, nutrition, adherence and lived response.
Digital twins: a research instrument
Computational models may help researchers simulate biology, design trials or prioritize candidates. The FDA’s discussion paper describes model credibility as context-specific: a model adequate for one decision may be inadequate for another.19
A routine virtual copy of an individual brain that safely tests drug combinations before prescribing does not yet exist. “Digital twin” should describe a model with declared inputs, validation and uncertainty—not a marketing metaphor.
Protect medicine from competition pressure
People should not have to medicate themselves to match an unhealthy schedule, conceal exhaustion or satisfy a workplace that treats sleep as weakness. Fair systems distinguish treatment and accommodation from nonmedical coercion. They protect confidential health information, provide genuine rest, evaluate workload and prevent access to a prescription from becoming an unofficial condition of study or employment.
The goal is not to shame treatment. It is to ensure that a medicine remains a freely chosen, clinically justified tool for the person—not a productivity demand imposed by everyone around them.
AI can extend performance—or interrupt learning
The decisive question is not whether AI was used. It is what the person can understand, remember, judge and create after using it. Immediate performance, durable learning and human development are three different outcomes.
Assisted performance
Did the task become faster, easier or more accurate while the system was present? This matters—but it measures the human-tool pair, not the person alone.
Learning
Can the learner later recall, explain and transfer the idea without assistance? A polished submission cannot answer this question.
Development
Did the experience strengthen judgment, curiosity, originality, responsibility and the ability to learn the next thing?
AI should remove friction that does not teach while preserving the effort through which knowledge, judgment, originality and responsibility are formed.
A revealing classroom result
In a 2025 field experiment involving nearly 1,000 secondary-school mathematics students, unrestricted GPT assistance improved performance during practice. Yet when access was removed, those students scored about 17% below the control group on the unaided examination. A purpose-built tutor that used staged hints and encouraged students to attempt problems avoided that measured learning loss, although it did not produce a significant unaided advantage over the control.20
The lesson is not that all chatbots make people less intelligent. It is narrower and more useful: a tool can improve the work visible on the screen while leaving less knowledge inside the learner. Guardrails that preserve effort matter.
Another randomized study, in a Harvard introductory physics course, found higher immediate post-test performance and shorter median study time with a carefully engineered AI tutor than with an active-learning class.21 But the experiment covered two lessons, used immediate tests and did not measure long-term retention. Its tutor contained expert-prepared material, staged questioning and course-specific design. It is evidence that a well-built tutor can help—not that a general chatbot can replace teachers.
| Moment | Answer engine | Learning partner |
|---|---|---|
| Before effort | Produces a complete response immediately. | Asks what the learner already knows and requests a first attempt. |
| During difficulty | Removes the difficulty that carries the practice. | Offers the smallest useful hint, counterexample or diagnostic question. |
| After success | Ends when the output looks finished. | Asks for explanation, verification and a new transfer problem. |
| Assessment | Rewards the appearance of competence. | Checks what can be done independently, after a delay, in a new context. |
| Human role | User becomes editor of machine output. | Learner remains reasoner, author and accountable decision-maker. |
A practical learning loop
Teachers become more important, not less
A teacher does more than deliver information. Teachers select worthwhile goals, recognize misconceptions, judge when struggle is productive, connect knowledge with consequence, cultivate discussion, protect vulnerable learners and assess what a person can do independently. AI can help generate examples, translate material, create practice or prepare a first feedback pass. The educator remains the designer, witness and accountable professional.
UNESCO’s guidance calls for privacy protection, age-appropriate use, ethical validation and a human-centred approach to generative AI in education.22 That is more than a compliance exercise. Students need spaces to think without surveillance, alternatives when a system is inaccessible, and human appeal when automated tools influence opportunity.
Fluency is not evidence
NIST uses the term confabulation for confidently presented false or internally inconsistent generated content. It also identifies automation bias—the tendency to defer excessively to automated output—and homogenization among generative-AI risks.23
For important claims
- Open the cited source; do not trust that it exists.
- Check that the source supports the exact sentence.
- Recalculate consequential numbers.
- Use primary or authoritative evidence where possible.
For important decisions
- Name the person who remains accountable.
- Define when independent review is mandatory.
- Preserve provenance, uncertainty and correction history.
- Give affected people a real path to question or appeal.
At work, the frontier is jagged
Controlled and field studies show genuine productivity gains in some bounded tasks. In an experiment with 453 professionals, generative AI reduced time on short occupational writing tasks by 40% and increased independent quality ratings by 18%.24 In a study of 758 consultants, AI users were faster and performed better on selected tasks inside the model’s capability frontier—but were less likely to reach the correct answer on a task deliberately placed outside it.25
Deployment to 5,172 customer-support agents increased issues resolved per hour by 15% on average, with larger gains among less experienced workers.26 This suggests that systems can diffuse some expert practices. It does not mean every occupation, expert or workflow receives the same benefit.
A meta-analysis of 106 experiments found that human–AI systems generally outperformed humans alone, yet on average performed worse than whichever agent—human or AI—was best by itself.27 “Human plus AI” is therefore a design problem, not an automatic victory. Teams need calibrated trust, clear handoffs and a way to recognize when the machine has crossed from helpful to confidently wrong.
| Work type | Possible AI role or human-led work | Human responsibility: always verify |
|---|---|---|
| Transformation | Formatting, transcription, translation drafts, routine variants and structured extraction. | Accuracy, omitted context, confidentiality and accessibility. |
| Exploration | Alternative hypotheses, questions, counterarguments and scenario sketches. | The evidence behind each option and whether possibilities were mistaken for facts. |
| Analysis | First-pass categorization, code suggestions and repetitive comparisons. | Assumptions, calculations, edge cases, security and representativeness. |
| Judgment | Human goals, moral trade-offs, lived context, accountability, original direction and final decisions. | Whether the named human truly understood and chose the result. |
Tasks change before whole occupations disappear
The International Labour Organization’s refined 2025 index estimated that one in four workers worldwide is in an occupation with some exposure to generative AI, while 3.3% of global employment falls in its highest-exposure category. Exposure was greater in high-income economies and, in the highest category, among women. The ILO judged task transformation more likely than complete replacement because most occupations combine automatable and human-dependent work.28
Exposure is not a layoff forecast. It describes technical overlap with tasks, not adoption, economic demand, bargaining power or a fixed timeline. But productivity is not job security either. Organizations and governments must measure who receives the gains, who bears transition costs and whether new roles provide real development rather than permanent oversight of machines.
One danger deserves early attention: if employers automate the junior tasks through which people learn a profession, they may gain short-term efficiency while weakening the supply of future experts. Apprenticeship must be redesigned, not deleted. New entrants need supervised practice, explanation, increasing responsibility and regular opportunities to perform core work without AI.
For learners
Measure unaided recall and transfer, not only the quality of AI-assisted output. Protect time for reading, calculation, writing and problem solving without the tool.
For organizations
Test systems against real workflows; track correction time, error severity, skill growth and job quality—not speed alone.
For society
Share productivity gains through education, transition support, accessibility and stronger work—not only lower headcount.
Intelligence matters—and deserves serious respect
Cognitive ability affects how people learn, recognize patterns, solve unfamiliar problems and navigate complexity. Protecting it from injury, toxic exposure, disease, chronic sleep loss and preventable stress is therefore a serious personal and public responsibility.
Exceptional ability joined with disciplined learning can produce discoveries, explanations, designs and judgment that no tool can simply substitute. A society benefits when it recognizes such minds early, challenges them deeply, protects their independence and gives their work fair credit.
What a higher score can honestly mean
A higher score on a valid cognitive assessment is evidence of stronger performance in the abilities that assessment actually measures. Those abilities are real and consequential. In the right context, they can support faster learning, more complex reasoning and the capacity to solve problems that require unusually deep abstraction.
That statement should not be weakened into “scores mean nothing.” Nor should it be stretched into “one score measures every valuable property of a person.” No IQ test fully captures acquired knowledge, intellectual courage, creativity, moral judgment, practical wisdom, motivation, consciousness or the future contribution someone will make. Measurement earns respect by remaining precise.
Intelligence is not a toy purchased from a shelf. Its development reflects inherited differences, physical brain development, health, education, practice, opportunity and a lifetime of accumulated learning. Expertise is especially costly: it can embody decades of attention, correction, memory, sacrifice and experience. When a knowledgeable person is lost, neglected or prevented from contributing, tools and databases do not automatically recreate the organized understanding that existed in that mind.
Education can raise measured intelligence
A meta-analysis of 42 datasets and more than 600,000 participants used several quasi-experimental designs and estimated roughly 1–5 additional IQ points for an extra year of education. The authors described education as the most consistent, robust and durable method then identified for raising intelligence.29
This is an average causal estimate, not a promise for every learner. It nevertheless rejects fatalism: policy, teaching and sustained learning can develop measured cognitive ability.
Do more than admire the result
- Offer depth, acceleration and intellectual peers where needed.
- Protect uninterrupted time and freedom to pursue difficult questions.
- Credit original work and compensate expertise fairly.
- Do not exploit the most capable person as an infinite shared resource.
- Protect cognitive health, privacy and the right to refuse enhancement.
- Let intelligent people be human, uncertain and still learning.
Capability should shape opportunity—not basic rights
Different minds can contribute at very different levels to a particular problem. It is reasonable to recognize demonstrated ability, seek expert guidance and entrust demanding work to people prepared to do it. Excellence deserves celebration, and rare intellectual contribution can carry enormous social importance.
Yet a cognitive score cannot license coercion, neglect or loss of dignity. Rights are a floor under every person; respect for excellence is the height a culture makes possible above that floor. We do not protect intelligence by using it to justify cruelty. We protect it by building conditions in which every mind can develop and exceptional minds can reach farther.
| Level | Protect | Cultivate | Recognize |
|---|---|---|---|
| Individual | Sleep, physical health, sensory care, safety, protection from substance-related harm and freedom from coerced drug use. | Deliberate study, retrieval, difficult practice, reflection and broad knowledge. | Track real capability and growth, not appearance or confidence alone. |
| Education | Safe environments, nutrition, support for disability and protection from chronic disruption. | Excellent teaching, advanced pathways, libraries, laboratories and time to think. | Identify both unmet need and advanced readiness without shame. |
| Work | Reasonable load, intellectual autonomy, privacy and protection from compulsory enhancement. | Apprenticeship, research time, expert peers and increasingly complex responsibility. | Fair authorship, compensation, decision authority and public credit. |
| Society | Clean environments, public health, peace, access to care and strong rights. | Universal education plus routes for exceptional depth and lifelong return to learning. | Celebrate discovery, teaching, repair, wise judgment and original contribution. |
Original thought needs both solitude and return
Time alone can protect a question from premature direction. Time with others can test, strengthen, resource and celebrate the answer. Creativity is not a permanent choice between isolation and community; it is a rhythm between them.
Step away
Without an audience, instruction or immediate comparison, attention can wander across personal memories, unusual associations and questions no one else has assigned. An idea gets time to become itself before it must defend itself.
- Observe before asking what others think.
- Write or sketch an independent first version.
- Let an unresolved problem incubate.
Come back
Once an original direction exists, other minds become indispensable. They find errors, supply missing expertise, build tools, provide courage, open institutions, communicate the work and help a private insight become shared progress.
- Invite criticism without surrendering authorship.
- Find collaborators whose abilities are complementary.
- Support, promote and celebrate genuine contribution.
Why stepping away can help
Groups can focus attention, but they can also anchor it: the first confident suggestion can change what everyone else considers, conversation can interrupt unfinished associations, and social approval can reward familiar directions. The same effect can occur when a person asks AI for ideas before listening to their own mind.
Experimental work on creative incubation found that an undemanding task associated with more mind wandering improved later performance on previously encountered creative problems compared with demanding activity, rest or no break.30 This does not mean all mind wandering is productive or that loneliness improves creativity. It supports a modest principle: mental space and temporary release from focused control can sometimes help an unfinished problem reorganize.
Research on social influence and creativity likewise shows no simple “groups are good” or “groups are bad” verdict. Evaluation pressure, conformity, production blocking, diversity, dissent and the sequence of individual and collective work all matter.31 A strong design often lets people generate independently first, then compare, combine and challenge ideas together.
Chosen solitude
Voluntary, bounded and restorative. The person can return when ready and remains connected to practical support.
Harmful isolation
Imposed, unwanted or prolonged disconnection that removes care, feedback, safety and belonging. It should not be romanticized.
Generative community
People who protect difference, give honest feedback, share resources, preserve credit and welcome the thinker back without demanding conformity.
A better brain future must still belong to the person
Enhancement is not responsible merely because it produces a measurable gain. The person must retain meaningful consent, mental privacy, authorship, continuity of care, the power to refuse and the power to stop ongoing use where feasible. Irreversible interventions require a higher threshold of evidence and consent. Benefits must not depend on surrendering the mind to an employer, school, state or platform.
Voluntary means refusal is real
Consent must be informed, specific and free from economic, educational or institutional pressure. Refusal and withdrawal cannot quietly carry punishment. Reversibility and exit options should exist where possible; irreversible effects must be made unmistakably clear before consent.
Neural data is not ordinary telemetry
Collection should be minimized, tightly purposed, secured and deletable where technically and legally possible. Retention limits and any necessary exceptions should be explained before consent. Inferences can be sensitive even when raw signals look meaningless.
Access shapes the outcome
A breakthrough that only wealthy people can use may widen inequality; a cheap but coercive system can also distribute harm widely.
No abandoned minds
Implanted or dependent users need long-term maintenance, cybersecurity, clinical support and an exit plan if a provider disappears.
Global rules are beginning to catch up
In November 2025, UNESCO’s Member States adopted the first global normative framework on the ethics of neurotechnology. It emphasizes dignity, mental privacy, affordability, explicit consent and transparency; it warns against non-therapeutic use in children and against workplace monitoring that profiles employees.32 The recommendation is not a self-enforcing global law, but it gives governments and institutions a common direction.
The Council of Europe has separately examined neural data through the lens of Convention 108+, emphasizing protections for mental privacy while permitting responsible scientific progress.33 The OECD’s recommendation on responsible innovation in neurotechnology likewise calls for safety, inclusivity, deliberation, stewardship of personal brain data, oversight and anticipation of misuse.34
AI governance increasingly reaches education and employment too. Since 2 February 2025, the European Union’s AI Act has prohibited emotion inference in workplaces and educational institutions except for uses intended for medical or safety reasons. It also classifies certain systems that influence educational or employment access as high-risk; the principal obligations for these Annex III systems apply from 2 December 2027.35 These categories recognize an essential fact: a model that grades, hires or monitors can shape a life even if it never touches the brain.
| Test | Question | Minimum safeguard |
|---|---|---|
| Purpose | What exact human need is served? | A narrow use case and measurable endpoint; no mission creep by default. |
| Evidence | What stage of evidence supports the claim? | Independent review, transparent status and communication of uncertainty. |
| Proportionality | Is a more invasive or permanent intervention truly necessary? | Prefer the least intrusive effective option and review benefit continuously. |
| Consent | Can the person say no without losing work, education or care? | No retaliation, understandable choices, renewed consent after material updates. |
| Data | What is recorded, inferred, retained, combined or sold? | Minimization, encryption, purpose limits, access logs, deletion and breach plans. |
| Agency | Who can pause, override, disconnect or correct the system? | User control plus accountable human oversight for consequential actions. |
| Equity | Who is excluded, pressured or asked to carry risk? | Accessibility, fair coverage, representative testing and non-device alternatives. |
| Exit | What happens when a trial, vendor or job ends? | Maintenance funding, portability, safe removal where possible and continuity of care. |
Children require a higher threshold
Developing brains, limited legal autonomy and school pressure make “voluntary” enhancement difficult to interpret. Therapeutic benefit may justify a carefully reviewed intervention; convenience, behavioral conformity or competitive advantage rarely supplies the same justification.
Children should not lose education because a family refuses neural monitoring or generative AI, and they need age-appropriate explanations as well as adult consent.
Workers must not be optimized by force
A productivity bonus can become coercion when refusal threatens income. Employers should not demand brain monitoring, nonmedical stimulant use or continuous AI surveillance as the price of ordinary participation.
Collective bargaining, occupational health, anti-discrimination rules and worker representation belong in technology design—not after harm appears.
Fair credit is part of cognitive justice
Ideas do not become public goods by erasing their origin. Researchers, teachers, artists, communities and users whose knowledge trains or improves a system deserve transparent provenance, recognition and—where appropriate—compensation. Assistive technology should amplify a person’s authorship, not let institutions claim the person’s communication or labor as the machine’s achievement.
When many people help an idea grow, credit can be shared without denying the original contribution. Celebration is not scarce; authorship should be accurate.
Progress has a physical footprint
AI is not weightless: it runs through physical data centers that require electricity and infrastructure. The International Energy Agency’s 2025 report models rapidly rising data-center electricity demand while also examining how AI may improve energy systems.36 Biomedical technologies also carry laboratory, manufacturing, maintenance, supply-chain and disposal footprints. Responsible enhancement counts the full ledger: clinical benefit, labor, environmental burden and who lives near the infrastructure.
What is here, what may come next, what remains distant
Forecasts should be read as conditional pathways, not scheduled arrivals. Biology can fail, trials can reveal harm, regulation can change and a technically impressive system can prove unusable in daily life.
Use—with defined limits
- Genome editing for a small number of non-neurological diseases.
- Condition-specific brain stimulation and a few restorative implants.
- Medicines that treat attention or wake disorders.
- AI that assists tutoring and bounded knowledge-work tasks.
- Education and healthy conditions that develop and protect cognition.
Test—do not promise
- More durable home BCIs for speech and assistive control.
- Better closed-loop stimulation for defined disorders.
- Somatic genome-editing or epigenome-editing therapies for selected neurological diseases.
- More credible prediction in drug development and trial design.
- AI tutors that preserve effort and adapt to verified curricula.
Imagine—label honestly
- Reliable gene editing for high general intelligence.
- Uploading knowledge, memories or consciousness.
- A safe drug that durably raises IQ in healthy people.
- Implanted co-processors that expand working memory on demand.
- Accurate reading of unconstrained private thought.
Signs the future is moving closer
- Replicated, registered human trials with meaningful endpoints.
- Benefits that persist outside controlled laboratories.
- Independent safety evidence with long-term follow-up.
- Manufacturing, maintenance and access that work at scale.
- Governance that gives affected people actual power.
Reasons a forecast can fail
- A mechanism does not translate from animals to humans.
- The measured effect is too small or narrow to matter.
- Adverse effects appear only after longer exposure.
- Calibration, surgery, cost or support makes daily use impractical.
- People reject a system that violates autonomy or trust.
Build capacities that compound across every future
The safest preparation is not guessing one winning device. It is developing knowledge, reasoning, health and social structures that remain valuable whether a technology arrives early, late or never.
Deep knowledge
Facts and models stored in memory make reasoning faster, reveal errors and give new information somewhere to connect.
Learning skill
Retrieval, spacing, explanation, feedback and transfer turn exposure into durable ability.
Independent judgment
Source evaluation, probability, causal reasoning and moral clarity become more—not less—important around fluent machines.
Collaborative range
Listening, teaching, dissent, synthesis and fair credit let different minds solve problems none could finish alone.
A durable practice for individuals
- Protect the substrate. Treat sleep, movement, nutrition, hearing, vision, mental health, injury prevention and medical care as cognitive infrastructure.
- Learn something difficult without shortcuts. Build a real knowledge base in at least one domain and regularly solve problems unaided.
- Use AI after a first attempt. Let the system question, criticize or expand your work; do not make it the automatic origin of every idea.
- Alternate solitude and community. Give private thought time to form, then seek demanding feedback, complementary expertise and support.
- Audit any enhancement claim. Identify the evidence stage, population, endpoint, duration, risks, conflicts and regulatory status.
- Keep agency visible. Know which decisions you will not delegate and who remains answerable when a tool is wrong.
| Role | Start now | Measure | Do not trade away |
|---|---|---|---|
| Learners and families | Protect health, read deeply, practice unaided, verify generated material and ask for suitable challenge. | Retention, transfer, curiosity, independent work and well-being. | Privacy, childhood, sleep, authorship or the right to learn without a commercial platform. |
| Educators | Teach AI literacy, redesign assessment, retain no-AI practice and provide both support and advanced depth. | What students can explain and do later without the tool. | Teacher judgment, human relationship, equitable access and meaningful feedback. |
| Employers | Pilot narrowly, involve workers, redesign apprenticeships and document accountability. | Error cost, correction time, skill growth, job quality, distribution of gains and user trust. | Consent, rest, professional development, fair credit or safe refusal. |
| Policymakers and funders | Support independent trials, public education, long-term registries, accessibility and transition systems. | Health benefit, concentration of access and power, labor effects, environmental cost and redress. | Fundamental rights, public oversight or the capacity to govern after deployment. |
The aim is intelligence with sovereignty
Celebrate rising ability. Protect exceptional minds. Make excellent education widely available. Build tools that restore what injury or disease has taken. Let machines carry repetitive burden when that gives people more time for understanding, care, discovery and original work.
But keep the direction human. A civilization is not cognitively advanced if it can optimize attention while destroying freedom, generate answers while weakening learning, or read neural signals while refusing to listen to the person.
Key takeaways
- Restoration is the leading edge. The strongest present neurotechnology helps recover communication, movement, vision or control of disease.
- No technology can presently rewrite general intelligence on demand. Genetic, neural and drug claims must be kept at their real evidence stage.
- Intelligence and IQ growth matter. Education can improve measured ability, and exceptional expertise deserves protection, opportunity and credit.
- AI’s benefit depends on preserved effort. Judge a learning tool by later unaided understanding, not the polish of its assisted output.
- Solitude and community are partners. Private thought protects originality; trustworthy people help an idea survive, scale and serve.
- Rights are design requirements. Consent, mental privacy, equitable access, security, continuity, the power to refuse and the power to stop ongoing use where feasible must exist before deployment.
Frequently asked questions
Short answers to claims that are often blurred by advertising, science fiction or headlines.
Can scientists edit genes to make a person highly intelligent?
No validated clinical method can do this. General intelligence is influenced by many variants of small effect and by development, health, education and experience. Present genome-editing successes target comparatively specific disease mechanisms; heritable cognitive enhancement would add profound scientific, consent and social problems.
Can a brain implant make a healthy person smarter?
No implant has been shown to raise general intelligence in healthy people. Restorative BCIs can decode trained speech or movement intentions in selected participants, and stimulation can treat particular disorders. Those are important achievements, but they are not memory uploads or general cognitive expansion.
Are prescription stimulants proven study enhancers for healthy people?
They may alter alertness or selected acute laboratory tasks, but pooled effects in healthy, rested adults are small and task-specific. They have not been shown to produce durable increases in IQ, wisdom or life achievement, and nonmedical use carries medical, legal, dependence and fairness risks.
Does using AI weaken intelligence?
Not inevitably. AI can explain, translate, provide practice and reduce incidental burden. It becomes risky when it removes the very reasoning, recall or creation a person needs to develop. Attempt first, ask for limited support, verify, explain, transfer and periodically work without it.
Does a high IQ matter?
Yes. A valid higher score indicates stronger performance in the abilities measured, and those abilities can matter greatly for learning and complex problem solving. The score still does not contain every form of intelligence, knowledge, creativity, wisdom or character. Take cognitive excellence seriously without asking one measure to answer questions it was not built to answer.
Is being alone good for creativity?
Chosen, bounded solitude can protect attention and allow incubation; unwanted isolation can harm well-being and remove necessary feedback. A useful rhythm is independent idea formation followed by return to people who can test, support, improve and celebrate the work.
What is the safest enhancement available now?
There is no universal answer, but the strongest foundations remain education, appropriate healthcare, sleep, physical health, meaningful practice, supportive relationships and environments that protect concentration. Treat medical conditions with qualified care; do not substitute an unapproved product or consumer device for diagnosis or treatment.
Sources and further reading
Regulatory documents, primary studies, systematic reviews and international guidance used to distinguish current capability from emerging research and speculation.
All external source links in the following list open in a new browser tab.
-
FDA: first CRISPR-based gene therapy approval
U.S. Food and Drug Administration, 2023. Casgevy for sickle cell disease. -
Genome-wide association meta-analysis of intelligence
Savage et al., Nature Genetics, 2018. Large-scale evidence for a highly polygenic architecture. -
Human genome editing: recommendations
World Health Organization, 2021. Governance, registries, public engagement and international oversight. -
Heritable Human Genome Editing
International Commission convened by the U.S. National Academies and the Royal Society, 2020. -
NMPA: extradural BCI authorization
China’s National Medical Products Administration, 2026. Narrow assistive-glove indication after cervical spinal-cord injury. -
Long-term independent use of an intracortical BCI
Nature Medicine, 2026. Nineteen-month home speech and cursor use by one participant with ALS. -
Developing a hippocampal neural prosthetic
Hampson et al., Journal of Neural Engineering, 2018. Task-specific memory findings in epilepsy-monitoring participants. -
Subretinal photovoltaic implant for geographic atrophy
Published online in 2025; New England Journal of Medicine, 2026;394(3):232–242. See also the manufacturer’s 2026 CE-mark announcement. -
Partial recovery of visual function after optogenetic therapy
Sahel et al., Nature Medicine, 2021. Single-participant investigational report. -
FDA premarket approval: Flow FL-100
U.S. FDA, 2025. Prescription tDCS device for a defined adult major-depression indication. -
Prescription stimulants and cognition in healthy adults
Systematic review and meta-analysis, 2020. Acute, small and domain-specific effects. -
Modafinil prescribing information
DailyMed / U.S. National Library of Medicine. Approved indications, risks and interactions. -
FDA updates prescription-stimulant warnings
U.S. FDA, 2023. Misuse, abuse, addiction, overdose and safe-use communication. -
FDA approves first orexin-2 agonist for narcolepsy type 1
U.S. FDA, 2026. Oveporexton for adults with a defined orexin-deficiency disorder. -
Mevidalen in Lewy body dementia
Phase 2 randomized placebo-controlled trial, 2022. Cognitive endpoints were not met. -
A non-hallucinogenic psychedelic analogue with therapeutic potential
Cameron et al., Nature, 2021. Tabernanthalog cell and animal evidence. -
Psychedelic microdosing and cognitive functions
Systematic review and meta-analysis, 2026. No overall cognitive enhancement. -
FDA table of pharmacogenetic associations
Specific gene–drug relationships and careful distinctions between exposure and demonstrated outcomes. -
AI and machine learning in drug development
FDA discussion paper, revised 2025. Potential uses, validation and context-specific risk considerations. -
Generative AI without guardrails can harm learning
Bastani et al., PNAS, 2025. Field experiment in secondary-school mathematics. -
AI tutoring outperforms in-class active learning
Kestin et al., Scientific Reports, 2025. Short randomized crossover trial with a bespoke physics tutor. -
Guidance for generative AI in education and research
UNESCO, 2023. Human-centred design, privacy, validation and age-appropriate use. -
NIST Generative AI Profile
NIST AI 600-1, 2024. Confabulation, automation bias, privacy, homogenization and risk management. -
Experimental evidence on productivity effects of generative AI
Noy and Zhang, Science, 2023. Bounded professional writing tasks. -
The jagged technological frontier
Dell’Acqua et al., Organization Science, 2026. Preregistered experiment with knowledge workers. -
Generative AI at work
Brynjolfsson, Li and Raymond, Quarterly Journal of Economics, 2025. Deployment to customer-support agents. -
When combinations of humans and AI are useful
Vaccaro, Almaatouq and Malone, Nature Human Behaviour, 2024. Meta-analysis of 106 experiments. -
Generative AI and jobs: a refined global index
International Labour Organization, 2025. Task-level occupational exposure, not a prediction of job extinction. -
How much does education improve intelligence?
Ritchie and Tucker-Drob, Psychological Science, 2018. Meta-analysis of quasi-experimental evidence. -
Mind wandering facilitates creative incubation
Baird et al., Psychological Science, 2012. Experimental creative-problem-solving study. -
Social influence, creativity and innovation
Paulus and Dzindolet, Social Influence, 2008. Review of individual and group creativity. -
UNESCO adopts the first global neurotechnology ethics standard
UNESCO, 2025. Dignity, mental privacy, children, workplaces, inclusion and consent. -
Neurotechnology, neural data and Convention 108+
Council of Europe expert report, 2024. Privacy and data-protection implications. -
Recommendation on Responsible Innovation in Neurotechnology
OECD/LEGAL/0457, adopted 2019. -
European Union AI Act overview
European Commission. Risk-based requirements for prohibited and high-risk uses. -
Energy and AI
International Energy Agency, 2025. Electricity demand, infrastructure, security and potential energy-system benefits.
Educational and medical note: This article explains research and policy; it does not diagnose a condition, recommend a medicine or device, or replace individualized medical, legal or educational advice. Regulatory status and evidence can change. For any clinical decision, use current local guidance and a suitably qualified professional who can assess the person, indication, alternatives and follow-up.